InsidersTradesSigma
Follow the 株式会社PALTAC stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社PALTAC has logged 22 insider filings. Market capitalisation: €575.9bn. The latest transaction was filed on 17 July 2026 (Holding update). Among the most active insiders: FMR LLC. All data is openly available.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 株式会社PALTAC Hold (neutral), based on 4 analysts. Average price target: JP¥2,963.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,330 of 29,056 companies
55.8
score / 100
Value64
Quality48
FCF yld5.6%
Earn yld5.5%
EV/EBITDA10.6x
ROE7.3%
Gross mgn7.5%
Net mgn1.8%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 July 2026
Declarations22 total
33.71% mcap54.0% of flowShareXTKSEDINET:S100YR77
30.09% mcap100.0% of flowShareXTKSEDINET:S100YPWY
ShareXTKSEDINET:S100YDY8
ShareXTKSEDINET:S100YDY3
ShareXTKSEDINET:S100YDXV
ShareXTKSEDINET:S100YDXQ
ShareXTKSEDINET:S100YCPB
ShareXTKSEDINET:S100Y9ET
ShareXTKSEDINET:S100SBDI
ShareXTKSEDINET:S100QHP5
22 of 22 declarations
Acerca de 株式会社PALTAC
PALTAC Corporation es una empresa japonesa especializada en la distribución de productos farmacéuticos y de salud. Opera principalmente en el mercado de la salud en Japón.